Puma Biotechnology | PBYI - EPS Earnings Per Share


Puma Biotechnology reported $0.41 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Daiichi Sankyo JPY 46.79 22.27 Dec/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 0.97 0.19 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
Incyte USD 1.8 0.46 Dec/2025
MacroGenics USD 0.27 0.84 Sep/2025
Moderna USD -2.11 1.6 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Takeda JPY 65.74 73.57 Dec/2025
TG Therapeutics USD 0.14 2.29 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025